Cell Culture Media for Vaccine Market size Worth USD 2.22 Billion by 2026 and Anticipate a Growth by 7.7% CAGR by Future Analysis, Business Overview and Estimation

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global Cell Culture Media for Vaccine Market, by Media Type (Bovine Derived, Porcine Derived, and Animal-Free/Serum-Free Cell Culture), By Application (Human Vaccine and Animal Vaccine), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1,235.5 million in 2017 and is estimated to exhibit a CAGR of 7.7% over the forecast period (2018-2026), as highlighted in a new report published by Coherent Market Insights.

Get Sample PDF (Including COVID-19 Impact Analysis, Full TOC, Tables and Figures) of Cell Culture Media for Vaccine, https://www.coherentmarketinsights.com/insight/request-pdf/2608

Major market players are focusing on research and development, in order to develop novel research grade products to cater to the need of researchers. For instance, in November 2017, Proliant Biologicals launched New Zealand manufactured Reagent Grade (Fatty Acid-free) BSA. The product is derived from New Zealand-origin healthy animals.

Moreover, increasing number of government initiatives to prevent certain diseases and epidemic caused due to vaccine-preventable diseases are the factors that are expected to augment the market growth over the forecast period. Furthermore, increasing number of countries are focusing on conducting national immunization programs to provide vaccination and promote awareness about advantages of vaccination to fight fatal diseases with natural immunity among adults as well as children. For instance, in 2015, the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) entered into a partnership with the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) to support the advanced development of new and better influenza vaccines as a part of inter-agency government effort in the U.S.

Moreover, major market players are focused on adopting growth strategies such as mergers and acquisitions to expand their product portfolio and strengthen their position in the global market. For instance, Merck KGaA, a parent company of Merck Millipore, acquired the U.S.-based life science company, Sigma-Aldrich Corporation, at US$ 17 Bn through its U.S. subsidiary EMD Millipore, in November 2015. A combined entity known as MilliporeSigma was formed in the U.S. market and this acquisition made Merck Millipore one of the top three players in the global life science market.

Browse 33 Market Data Tables and 27 Figures spread through 197 Pages and in-depth TOC on ‘Cell Culture Media for Vaccine Market’- Global Forecast to 2026, by Media Type (Bovine Derived, Porcine Derived, and Animal-Free/Serum-Free Cell Culture), by Application (Human Vaccine and Animal Vaccine), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the cell culture media for the market Press Release, click the link below: https://bit.ly/2Y6FfI8

Key Takeaways of the Global Cell Culture Media for Vaccine Market:

• The global cell culture media for vaccine market is expected to exhibit a CAGR of 7.7 % over the forecast period. The market growth is attributed to rising prevalence of infectious diseases, increasing number of government initiatives, coupled with increasing availability of innovative bovine blood plasma derivatives. For instance, in August 2017, Animal Free Research UK and the 3Rs-Centre Utrecht Life Sciences launched the Fetal Calf Serum (FCS)-free database. The database enables researchers to identify serum-free media for specific cell types, thereby contributing to the adoption of animal free media for research.
• On the basis of application type, human vaccine segment is estimated to account for a significant market share in the cell culture media for vaccine market in 2018, attributed to higher usage of bovine derived serum products in biotechnology research, vaccine production, cloning, and in vitro fertilization
• On the basis of media type, bovine derived segment is estimated to account for a significant market share in the cell culture media for vaccine market in 2018, as manufacturing of viral vaccines require fetal bovine serum or other sera as a source of nutrition or growth media for the virus growth
• Major players operating in the global cell culture media for vaccine market include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE.

Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2608

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.